Evaluation of the proper dosage of lapatinib and its safety in dogs
Lapatinib is a low-molecular-weight agent targeting the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). It is one of the antitumor agents used against advanced breast cancer in human. We intended to apply it against canine mammary gland tumors (cMGTs). To...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tokyo Metropolitan Institute of Medical Science
2020
|
Online Access: | http://psasir.upm.edu.my/id/eprint/88878/1/DOG.pdf http://psasir.upm.edu.my/id/eprint/88878/ https://www.jstage.jst.go.jp/article/trs/2/3/2_2020-013/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Putra Malaysia |
Language: | English |